Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Endocrine Connections|October 15, 2017
Clinical relevance of androgen receptor alterations in prostate cancerEmma Jernberg, Anders Bergh, Pernilla Wikström
BMC Cancer|May 2, 2015
Wilms' tumor gene 1 regulates p63 and promotes cell proliferation in squamous cell carcinoma of the head and neckXingru Li, Sofia Ottosson, Sihan Wang, et al.
Plos One|November 19, 2013
Characterization of prostate cancer bone metastases according to expression levels of steroidogenic enzymes and androgen receptor splice variantsEmma Jernberg, Elin Thysell, Erik Bovinder Ylitalo, et al.
Plos One|June 10, 2016
Extratumoral Heme Oxygenase-1 (HO-1) Expressing Macrophages Likely Promote Primary and Metastatic Prostate Tumor GrowthSofia Halin Bergström, Maria Nilsson, Hanibal Adamo, et al.
The Prostate|February 2, 2017
High levels of the AR-V7 Splice Variant and Co-Amplification of the Golgi Protein Coding YIPF6 in AR Amplified Prostate Cancer Bone MetastasesErik Djusberg, Emma Jernberg, Elin Thysell, et al.
International Journal of Molecular Sciences|April 20, 2018
Bone Cell Activity in Clinical Prostate Cancer Bone Metastasis and Its Inverse Relation to Tumor Cell Androgen Receptor ActivityAnnika Nordstrand, Erik Bovinder Ylitalo, Elin Thysell, et al.
European Urology|August 8, 2016
Subgroups of Castration-resistant Prostate Cancer Bone Metastases Defined Through an Inverse Relationship Between Androgen Receptor Activity and Immune ResponseErik Bovinder Ylitalo, Elin Thysell, Emma Jernberg, et al.
Plos One|October 27, 2015
High Lysyl Oxidase (LOX) in the Non-Malignant Prostate Epithelium Predicts a Poor Outcome in Prostate Cancer Patient Managed by Watchful WaitingMaria Nilsson, Christina Hägglöf, Peter Hammarsten, et al.
Clinical Epigenetics|July 1, 2021
A novel DNA methylation signature is associated with androgen receptor activity and patient prognosis in bone metastatic prostate cancerErik Bovinder Ylitalo, Elin Thysell, Mattias Landfors, et al.
Molecular Oncology|June 5, 2019
Gene expression profiles define molecular subtypes of prostate cancer bone metastases with different outcomes and morphology traceable back to the primary tumorElin Thysell, Linda Vidman, Erik Bovinder Ylitalo, et al.
Pageof 1